Microbot Medical Launches LIBERTY Robotic System in U.S. Market
Microbot Medical Inc. has launched the limited market release of its LIBERTY® Endovascular Robotic System in the U.S. The company has established the necessary infrastructure, including a commercial team and logistics partnership, targeting high procedure volume areas to gather insights before a full launch at the Society of Interventional Radiology conference in April 2026. This news was generated by Public Technologies and is for informational purposes only.
Microbot Medical Inc. has expanded its operations in the U.S. with the commencement of the limited market release of its LIBERTY® Endovascular Robotic System. The company has completed the necessary infrastructure to support the introduction, including hiring a core commercial team and establishing a logistics partnership. This limited release targets high procedure volume regions and aims to gather real-world insights ahead of a planned full market launch at the Society of Interventional Radiology conference in April 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9568906-en) on November 05, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
